Marvin 11291210402D 25 29 0 0 1 0 999 V2000 8.3484 -4.5188 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 9.0773 -4.1329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6192 -4.1329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.8063 -4.5188 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.0773 -3.2753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.0636 -5.3336 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 10.9213 -5.3336 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 11.1786 -4.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4495 -4.0472 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 10.4495 -3.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4495 -2.3319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10.4924 -6.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.7789 -5.3336 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 9.2489 -5.3336 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 8.3484 -5.3766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6341 -5.7890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6341 -6.6138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0628 -6.6138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.3484 -7.0263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.9019 -7.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.9019 -6.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0628 -5.7890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1876 -7.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.6562 -7.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7771 -7.0263 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15 1 1 0 0 0 0 1 2 1 0 0 0 0 1 3 1 6 0 0 0 2 4 1 0 0 0 0 2 5 2 0 0 0 0 4 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 4 9 1 0 0 0 0 9 10 1 6 0 0 0 10 11 3 0 0 0 0 7 12 1 0 0 0 0 12 6 1 0 0 0 0 7 13 1 1 0 0 0 6 14 1 1 0 0 0 15 16 1 0 0 0 0 15 22 1 0 0 0 0 16 17 1 0 0 0 0 17 19 1 0 0 0 0 18 22 1 0 0 0 0 24 18 1 0 0 0 0 18 19 1 0 0 0 0 23 20 1 0 0 0 0 24 20 1 0 0 0 0 23 17 1 0 0 0 0 20 21 1 0 0 0 0 15 21 1 0 0 0 0 18 25 1 0 0 0 0 M END > CHEBI:71272 > saxagliptin > A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2S)-amino(3-hydroxyadamantan-1-yl)acetic acid with the amino group of (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carbonitrile. Used in its monohydrate form for the treatment of Type II diabetes. > 3 > BMS-477118; BMS 477118; (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile > (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile > saxagliptin > C18H25N3O2 > 315.41000 > 315.19468 > 0 > [H][C@]12C[C@@H](C#N)N(C(=O)[C@@H](N)C34CC5CC(CC(O)(C5)C3)C4)[C@@]1([H])C2 > InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1 > QGJUIPDUBHWZPV-SGTAVMJGSA-N > 361442-04-8 > 10201614 > 361442-04-8 > DB06335 > D08996 > Saxagliptin > 22001114; 22066527; 22081481; 22098472; 22132773; 22149373; 22192246; 22221000; 22232748; 22248301; 22292415; 22313154; 22313172; 22334441; 22349123; 22475049; 22496391; 22564773; 22668067; 22776778; 22823746; 22828124; 22932707; 22943617; 23137182 $$$$